Skin Cancer
Mole count and genetics strongly impact mole-linked melanoma risk, while sun exposure affects both melanoma types equally.
NF1-mutant melanoma may respond to EGFR inhibitors, offering hope for patients resistant to immunotherapy.
Patient-derived cells have the potential to enhance drug screening tools and improve patient outcomes.
Researchers identified the pathologic and clinical characteristics of patients who experience disease relapse.
A troubling rise in sun exposure and inconsistent sunscreen use may be linked to incidence of skin cancer in Canada.
Parkinson's disease and melanoma are believed to be linked due to DNA double-strand break repair thus cell proliferation.
This provides rationale for the clinical evaluation of defactinib and avutometinib in the treatment of melanoma metastases.
A study has uncovered a novel method to enhance immunotherapy for melanoma by targeting a protein known as MARCO.
Dr. John Fruehauf details how novel therapies have improved the landscape of metastatic melanoma care.
The main features of intestinal inflammation are reproduced as a biomarker for response to immune checkpoint inhibition.
Advertisement
Expert Interviews on Oncology
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.